24 Stratos LV/LV-T Technical Manual

Table 1: Patient Demographics at Enrollment

Characteristic

Group1

 

Group 2

 

 

Group 3

 

P-value

 

Other Medical

 

N=29

 

N=36

 

N=17

 

 

History

 

 

 

0.287**

 

Diabetes

13

(44.8%)

 

9 (25.0%)

 

4 (23.5%)

 

 

Chronic Lung

7 (24.1%)

 

16

(44.4%)

 

7 (41.2%)

 

0.211**

 

Disease

12

(41.4%)

 

12

(33.3%)

 

5 (29.4%)

 

0.791**

 

Thyroid Disease

 

 

 

 

Chronic Kidney

4 (13.8%)

 

5 (13.9%)

 

1 (5.9%)

 

0.836**

 

Disease

7 (24.1%)

 

10

(27.8%)

 

6 (35.3%)

 

0.726**

 

Prior Ischemic

 

 

 

 

Stroke or TIA

1

(2.3%)

 

3

(6.0%)

 

2 (8.0%)

 

0.653**

 

Prior Embolic

 

 

 

 

Events (non-

 

 

 

 

 

 

 

 

 

 

 

cerebrovascular)

 

 

 

 

 

 

 

 

 

 

 

*One-way ANOVA, ** Chi-Square test (2-sided)

Table 2 provides a summary of the AF medical history. Table 3 provides a summary of cardiac medications patients were taking at the time of enrollment. Please note some categories may equal more than 100% as several categories allow more than one response. In some cases, complete demographic data was not provided for all patients. There were no statistical differences in AF medical history and cardiac medication at enrollment between the 3 groups.